{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-127352","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2023-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.363129+00:00","generated_at":"2026-06-07T10:20:07.013350+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Standard BioTools and SomaLogic update merger presentation; target $300M+ revenue, $80M synergies by 2026","bullets":["All-stock merger: SLGC shareholders receive 1.1100 LAB shares per share; expected close Q1 2024.","Pro-forma combined 2026E revenue >$300M and $80M run-rate cost synergies fully achieved by 2026.","Combined cash at close >$500M; ownership: SLGC ~57%, LAB ~43% (incl. Series B preferred).","Shareholder vote set for Jan 4, 2024; supportive voting agreements from ~16% of LAB and ~1% of SLGC shareholders.","Presentation defends merger against Madryn allegations, citing premium, governance, and reduced execution risk."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-127352","json":"https://secwatch.observer/filing/0001104659-23-127352.json","markdown":"https://secwatch.observer/filing/0001104659-23-127352.md","text":"https://secwatch.observer/filing/0001104659-23-127352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465923127352/0001104659-23-127352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465923127352/tm2333207d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:20:07.013350+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}